Richard Nolan Townsend, Chief Executive Officer at Lexeo Therapeutics, Inc. (LXEO), sold 26,118 shares at $8.94 ($234K) on 2025-10-17, disclosed to the SEC on 2025-10-17.
Open-market sale of $234k LXEO by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.94 | 12,985 | $116K | 49.7% |
| 2 | $8.94 | 12,985 | $116K | 49.7% |
| 3 | $9.56 | 148 | $1K | 0.6% |
| Total | $8.94 avg | 26,118 | $234K | 100% |
| Filing → |
| LXEO | SELL | 2026-05-20 | $17K | — | Filing → |
| LXEO | SELL | 2026-04-07 | $313K | — | Filing → |
| LXEO | SELL | 2026-02-20 | $65K | — | Filing → |